Summit Therapeutics Inc. (SMMT)
19.09
-1.60 (-7.73%)
At close: Mar 03, 2025, 3:59 PM
18.89
-1.07%
Pre-market: Mar 04, 2025, 08:03 AM EST
Summit Therapeutics Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 |
Cash & Equivalents | 104.86M | 71.42M | 348.61M | 71.79M | 66.42M | 49.96M | 35.23M | 28.45M | 35.08M | 23.22M | 16.97M | 3.35M | 5.34M | 3.26M | 5.14M | 9.72M | 3.92M | 20.06M | 35.87M | 22.55M | 26.66M | 145.96K |
Short-Term Investments | 307.49M | 114.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20.7M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 1.47 | 0.00 | -0.00 | 0.89 | -0.00 | 1.97 | -0.00 | n/a |
Other Long-Term Assets | 2.55M | 5.28M | 577K | 170K | 21.26M | 3.27M | 1.00 | -0.00 | n/a | n/a | 1.00 | n/a | n/a | -3.26M | -5.14M | -9.72M | -3.92M | -20.06M | -35.87M | -1.86M | -26.66M | n/a |
Receivables | n/a | 848K | 349K | 1.46M | 10.19M | 5.29M | n/a | 11.09M | n/a | 2.28M | n/a | n/a | n/a | n/a | n/a | n/a | 1.05M | 1.46M | 1.27M | 0.00 | n/a | n/a |
Inventory | n/a | n/a | 301.5M | 7.16M | -11.71M | 1.56 | n/a | n/a | 110.56K | 563.1K | 4.16M | 1.00 | n/a | n/a | n/a | n/a | 563.98K | 670.13K | 369.35K | 48.2K | n/a | n/a |
Other Current Assets | 11.4M | 2.62M | 301.99M | 8.36M | 11.07M | 13.47M | 25.99M | 22.28M | 5.45M | 6.46M | 5.26M | 1.76M | 1.27M | 890.36K | 761.18K | 881.87K | 2.27M | 3.11M | 2.19M | 965.74K | 175.1K | n/a |
Total Current Assets | 423.75M | 189.71M | 656.71M | 97.31M | 66.42M | 62.11M | 61.29M | 50.8M | 41.67M | 29.7M | 22.89M | 5.11M | 6.61M | 4.15M | 5.9M | 10.6M | 7.79M | 25.3M | 38.43M | 23.57M | 26.84M | 145.96K |
Property-Plant & Equipment | 7.4M | 6.06M | 5.08M | 3.48M | 1.28M | 1.2M | 807.92K | 1.15M | 144.99K | 118.21K | 82.87K | 70.93K | 36.33K | 233.97K | 411.45K | 535.2K | 5.35M | 8.49M | 5.15M | 2.25M | 1.88K | n/a |
Goodwill & Intangibles | 1.86M | 1.89M | 1.8M | 12.41M | 13.54M | 8.87M | 16.29M | 24.44M | 5.17M | 5.89M | 6.25M | 5.76M | 270.1K | 1.73M | 1.74M | 7.25M | 6.95M | 35.59M | 2.86M | 49.98K | 37.66K | n/a |
Total Long-Term Assets | 11.81M | 13.24M | 7.46M | 16.06M | 36.08M | 13.34M | 17.09M | 25.58M | 5.31M | 6.01M | 6.33M | 5.83M | 306.42K | 1.97M | 2.15M | 7.78M | 12.3M | 44.08M | 8.01M | 2.3M | 39.54K | n/a |
Total Assets | 435.56M | 202.95M | 664.17M | 113.37M | 102.5M | 75.46M | 78.39M | 76.38M | 46.98M | 35.71M | 29.22M | 10.94M | 6.91M | 6.12M | 8.06M | 18.38M | 20.09M | 69.38M | 46.44M | 25.87M | 26.88M | 145.96K |
Account Payables | 4.64M | 2.67M | 355K | 4.37M | 6.14M | 2.63M | 5.8M | 12.49M | 1.13M | 1.02M | 5.38M | 575.68K | 401.19K | 584.15K | 525.39K | 238.04K | 972.87K | 3.61M | 2.26M | 871.13K | 33.89K | n/a |
Deferred Revenue | n/a | n/a | n/a | 7.94M | 8.37M | 1.17M | n/a | -18.03M | 8.64M | n/a | n/a | n/a | 924.01K | n/a | n/a | n/a | -1.52M | -2.81M | -453.11K | -988.95K | n/a | n/a |
Short-Term Debt | 3.77M | 2.81M | 21.46M | 1.09M | 390K | 988.19K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 194.57K | 373.84K | 129.46K | 117.82K | n/a | n/a |
Other Current Liabilities | 33.33M | 14.93M | 16.97M | 12.5M | 4.99M | 7.53M | 10.83M | 19.81M | 9.65M | 3.43M | 203.41K | 2.41M | 1.01M | 1.43M | 1.39M | 1.53M | 1.52M | 2.81M | 453.11K | 269.55K | 316.32K | 3.65K |
Total Current Liabilities | 41.73M | 20.41M | 38.78M | 25.62M | 19.89M | 9.9M | 16.88M | 26.81M | 13.62M | 4.57M | 5.67M | 3.08M | 2.41M | 2.02M | 1.91M | 1.76M | 2.69M | 6.6M | 2.84M | 1.26M | 350.21K | 3.65K |
Long-Term Debt | 3.45M | 103.29M | 497.3M | 1.25M | 75K | 318.56K | n/a | -16.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.7M | 2.43M | 1.17M | 1.23M | n/a | n/a |
Other Long-Term Liabilities | 1.63M | 1.56M | 1.43M | 3.22M | 2.51M | 2.2M | 3.28M | 5.73M | -39.87K | 7.27M | n/a | n/a | n/a | 321.91K | 324.41K | 1.89M | 1.9M | 2.35M | 2.31M | n/a | n/a | n/a |
Total Long-Term Liabilities | 5.08M | 104.85M | 498.73M | 4.47M | 3.15M | 4.44M | 5.71M | 35.59M | 37.73M | 1.05M | 1M | n/a | n/a | 321.91K | 324.41K | 3.39M | 5.08M | 8.71M | 3.49M | 1.23M | n/a | n/a |
Total Liabilities | 46.81M | 125.26M | 537.51M | 30.09M | 23.05M | 14.34M | 22.59M | 62.4M | 51.35M | 5.62M | 6.67M | 3.08M | 2.41M | 2.34M | 2.24M | 5.15M | 7.77M | 15.3M | 6.33M | 2.49M | 350.21K | 3.65K |
Total Debt | 7.22M | 106.1M | 518.76M | 2.78M | 465K | 699.64K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.9M | 2.8M | 1.3M | 1.35M | n/a | n/a |
Common Stock | 7.38M | 7.02M | 2.11M | 980K | 826K | 3.47M | 2.1M | 1.04M | 772.47K | 873.03K | 619.25K | 16.62M | 13.88M | 11.18M | 10.97M | 11.04M | 8.07M | 12.75M | 7.3M | 5.59M | 5.9M | 1.82K |
Retained Earnings | -1.21B | -993.26M | -378.33M | -299.55M | -214.74M | -97.61M | -99.8M | -114.51M | -92.21M | -67.43M | -45.59M | -74.53M | -61.74M | -54.75M | -50.91M | -43.9M | -52.84M | -28.35M | -8.11M | -1.99M | -86.61K | -40.14K |
Comprehensive Income | -2.29M | -2.45M | -1.89M | -2.2M | -3.79M | 22.03M | n/a | n/a | 25.74M | 27.29M | -3.21M | -3.21M | -3.07M | -1.74M | -1.6M | -5.23M | -3.17M | -2.45M | -917.99K | -228.49K | -1.88K | n/a |
Shareholders Equity | 388.75M | 77.69M | 126.65M | 83.28M | 79.45M | 61.12M | 55.8M | 13.98M | -4.37M | 30.1M | 22.55M | 7.85M | 4.5M | 3.78M | 5.82M | 13.22M | 12.33M | 54.08M | 40.11M | 23.38M | 26.53M | 142.31K |
Total Investments | 307.49M | 114.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 1.47 | 0.00 | -0.00 | 0.89 | -0.00 | 20.7M | -0.00 | n/a |